We are live on ! Find out more
ACH icon

Accendra Health
ACH

Delisted

ACH was delisted on the 16th of November, 2026.

118 hedge funds and large institutions have $34.8M invested in Accendra Health in 2026 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 48 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,604% more call options, than puts

Call options by funds: $852K | Put options by funds: $23K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.82% less ownership

Funds ownership: 81.54% → 79.72% (-1.8%)

16% less funds holding

Funds holding: 141 → 118 (-23)

30% less capital inflows, than outflows

Capital inflows: $19.5M | Capital outflows: $27.9M

46% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 48

55% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 40

Holders
118
Holders Change
-23
Holders Change %
-16.31%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
18
Increased
26
Reduced
48
Closed
40
Calls
$852​K
Puts
$23​K
Net Calls
+$829​K
Net Calls Change
-⁠$4.92​M

ACH Hedge Fund Activity: Q3 2026 in Review

118 of the 8,207 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q3 2026, worth a combined $34.8M — down 84% from $213M a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of ACH and 18 opened new positions — a net loss of 22 holders — while 48 trimmed existing stakes and 26 added.

The largest buyer was Bank of America, adding an estimated $9.02M. The largest seller was Invenomic Capital Management, exiting entirely with an estimated $9.6M sold.

  • 118 institutional investors held Accendra Health (ACH) as of Q3 2026, down from 141 in Q2 2026.
  • Funds reported $34.8M of Accendra Health stock for Q3 2026, down 84% quarter-over-quarter.
  • 18 funds opened new Accendra Health positions in Q3 2026 and 40 closed out, a net change of -22 holders.
  • The largest Accendra Health buyer in Q3 2026 was Bank of America, an estimated $9.02M added.
  • The largest Accendra Health seller in Q3 2026 was Invenomic Capital Management, an estimated $9.6M sold.

Based on aggregated 13F filings for Q3 2026.